Search
for
Sort by
Research 181–210 of 437
- The modern scientific interpretation of ancient wisdom: a review of the phytochemistry and pharmacology of Erzhi Pill and its constituent botanical drugs
- Natural products and their derivatives as candidate treatments for hair greying: from drug discovery to molecular mechanisms
- Nouvelles thérapeutiques dans la prise en charge de l’alopécie androgénétique
- The Role of Sex Hormones in Skin Health
- Androgen excess: a hallmark of polycystic ovary syndrome
- Síndrome postfinasterida y disfunción eréctil. Caso clínico y revisión de la literatura
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- Skin manifestations of hyperandrogenism: an update
- Intracrinology and Testosterone Pellet Therapy: An Enzyme-Aware, Symptom-Driven Approach to Hormone Optimization in Aging
- The Effect of Finasteride on Serum Cortisol and testosterone Levels in Rats
- Development and Validation of A C57BL/6 Mouse Model of Androgenetic Alopecia Through Testosterone Propionate Induction
- Artificial Intelligence in Hair Disorders: A Narrative Review
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- GC-MS Fatty Acid Profile and In silico Studies of Telfairia occidentalis Hook f. (Fluted Pumpkin) and Sphenostylis stenocarpa (African Yam bean) Seeds Oil on Human 5 Alpha Reductase II
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- Clinical Research Progress on Plum-Blossom Needle Combined Therapy for Androgenic Alopecia
- Nanotecnología en Tricología: Avances Terapéuticos y Perspectivas Futuras en el Tratamiento de las Alopecias
- Exploring the Mechanism of Platycladi Cacumen in Intervening Androgenetic Alopecia Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation
- Precision therapeutics in non-scarring alopecia: a systemic genomic and pathway-based framework for targeted interventions
- Multidimensional assessment of adverse events of finasteride：a real-world pharmacovigilance analysis based on FDA Adverse Event Reporting System (FAERS) from 2004 to April 2024
- Causal associations between plasma proteins and prostate cancer: a Proteome-Wide Mendelian Randomization
- Factors associated with early-onset androgenetic alopecia: A scoping review
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- A potential review of its traditional uses, Phytochemistry, pharmacology, and toxicity of Plumbago zeylanica
- Correlation between sebum level and severity of male androgenetic alopecia
- 5 Alpha - Reductase and Metabolic Syndrome in PCOS Patients
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Genetic Defects of Female Sexual Differentiation
- The role of hair follicles and Edar signalling in cutaneous wound healing
- Unravelling the link between insulin resistance and androgen excess